Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier and caused widespread disease in the past two decades. The development of a universal human coronavirus vaccine could prevent future pandemics. We characterize 198 antibodies isolated from four COVID-19+ subjects...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cell Rep
Auteurs principaux: Jennewein, Madeleine F., MacCamy, Anna J., Akins, Nicholas R., Feng, Junli, Homad, Leah J., Hurlburt, Nicholas K., Seydoux, Emilie, Wan, Yu-Hsin, Stuart, Andrew B., Edara, Venkata Viswanadh, Floyd, Katharine, Vanderheiden, Abigail, Mascola, John R., Doria-Rose, Nicole, Wang, Lingshu, Yang, Eun Sung, Chu, Helen Y., Torres, Jonathan L., Ozorowski, Gabriel, Ward, Andrew B., Whaley, Rachael E., Cohen, Kristen W., Pancera, Marie, McElrath, M. Juliana, Englund, Janet A., Finzi, Andrés, Suthar, Mehul S., McGuire, Andrew T., Stamatatos, Leonidas
Format: Artigo
Langue:Inglês
Publié: Cell Press 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216847/
https://ncbi.nlm.nih.gov/pubmed/34237283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.109353
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires